François Ravenelle
Gründer bei Inversago Pharma, Inc.
Profil
François Ravenelle was the founder of Inversago Pharma, Inc. which was founded in 2015, where he held the title of Chief Executive Officer & Director.
He previously worked as Director-Business Development at Labopharm, Inc. from 2002 to 2008, Director-Pharmaceutical Development at Theratechnologies, Inc., and Director-Pharmaceutical Development at Verlyx Pharma, Inc. from 2011 to 2013.
Dr. Ravenelle earned a doctorate degree from McGill University in 2002.
Aktive Positionen von François Ravenelle
| Unternehmen | Position | Beginn |
|---|---|---|
Inversago Pharma, Inc.
 Inversago Pharma, Inc. Pharmaceuticals: MajorHealth Technology Inversago Pharma, Inc. develops novel gastrointestinal drugs. The company was founded by Fran?ois Ravenelle in and is headquartered in Montreal, Canada. | Gründer | 01.01.2015 |
Ehemalige bekannte Positionen von François Ravenelle
| Unternehmen | Position | Ende |
|---|---|---|
Labopharm, Inc.
 Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada. | Corporate Officer/Principal | 01.01.2008 |
| THERATECHNOLOGIES INC. | Corporate Officer/Principal | - |
Verlyx Pharma, Inc.
 Verlyx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Verlyx Pharma, Inc. develops cancer treatments. It is a pharmaceutical company involved in the development of liver-targeting therapeutic agents for the treatment of liver diseases. The firm’s product VLX103, is a proprietary form of pentamidine that combines hepatoselective and hepatoprotective properties. The company was founded in 1999 by Terry Chow and David Griller and is headquartered in Montréal, Canada. | Corporate Officer/Principal | - |
Ausbildung von François Ravenelle
| McGill University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| THERATECHNOLOGIES INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Verlyx Pharma, Inc.
Verlyx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Verlyx Pharma, Inc. develops cancer treatments. It is a pharmaceutical company involved in the development of liver-targeting therapeutic agents for the treatment of liver diseases. The firm’s product VLX103, is a proprietary form of pentamidine that combines hepatoselective and hepatoprotective properties. The company was founded in 1999 by Terry Chow and David Griller and is headquartered in Montréal, Canada. | Health Technology |
Labopharm, Inc.
Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada. | Health Technology |
Inversago Pharma, Inc.
Inversago Pharma, Inc. Pharmaceuticals: MajorHealth Technology Inversago Pharma, Inc. develops novel gastrointestinal drugs. The company was founded by Fran?ois Ravenelle in and is headquartered in Montreal, Canada. | Health Technology |
